Pituitary tumours

The pituitary gland is a tiny structure, about the size of a pea, that sits in a small bony pocket at the base of the brain, just behind the eyes and the bridge of the nose. Despite its size, it is often called the body's "master gland" because it makes hormones that control many other glands. Hormones are chemical messengers that travel in the blood and tell different parts of the body what to do. The pituitary helps regulate growth, the thyroid gland, the adrenal glands, the production of breast milk, fertility, and the balance of water in the body.

A pituitary tumour is a growth of cells in or around this gland. Most are called pituitary adenomas (you may also see the newer medical term PitNET, short for pituitary neuroendocrine tumour). The reassuring news, repeated across cancer organisations such as the American Cancer Society and Cancer Research UK, is that almost all pituitary tumours are benign — meaning they are not cancer, do not spread to other parts of the body, and usually grow slowly.

These tumours are surprisingly common. Cleveland Clinic notes that studies of imaging scans and autopsies suggest as many as one in five people may have a small pituitary growth at some point in life, very often without ever knowing, because it causes no symptoms. Problems arise in only two ways: when a tumour makes too much of a hormone, or when it grows large enough to press on nearby structures.

Doctors sort pituitary tumours in a few helpful ways. Understanding these labels makes the rest of your care much easier to follow.

By whether they make hormones:

• Functioning (hormone-producing) tumours release too much of a particular pituitary hormone. The symptoms depend on which hormone is overproduced.
• Non-functioning tumours do not release extra hormones. They tend to be noticed only when they grow large enough to cause pressure symptoms, or are found by chance on a scan done for another reason.

By size: a tumour smaller than 10 millimetres is a microadenoma; one 10 millimetres or larger is a macroadenoma. According to Cleveland Clinic, macroadenomas are more common and more likely to press on surrounding tissue.

By the hormone involved. The main functioning types, with the rough frequencies reported by Cleveland Clinic, are:

• Prolactinoma (excess prolactin) — the most common, around 4 in 10 pituitary tumours. Prolactin is the hormone behind breast-milk production.
• Growth-hormone tumour (somatotroph adenoma) — about 2 in 10. Too much growth hormone causes acromegaly in adults or gigantism in children.
• ACTH tumour (corticotroph adenoma) — about 1 in 10. This drives the adrenal glands to make too much cortisol, causing Cushing's disease.
• TSH and gonadotrophin tumours — these are rare.

A very small number of pituitary growths are pituitary carcinomas — true cancers that can spread. The American Cancer Society stresses that these are extremely rare; the overwhelming majority of pituitary tumours are benign adenomas.

For most people, there is no clear reason why a pituitary tumour develops, and nothing you did caused it. Cleveland Clinic explains that the majority arise from random changes (mutations) in the DNA of a single cell, which then multiplies. These changes happen by chance and are not inherited.

A small share of pituitary tumours are linked to rare inherited conditions that run in families. These include:

• Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
• Carney complex
• Neurofibromatosis type 1
• Von Hippel-Lindau syndrome

If several close relatives have had pituitary or other hormone-gland tumours, mention this to your doctor, who may suggest seeing a specialist in inherited conditions. Pituitary tumours can occur at any age, but they are most often diagnosed in adults, and some types are seen a little more often in women. Importantly, there is no proven link to mobile phones, diet, or lifestyle — so there is no reason to blame yourself.

Many pituitary tumours cause no symptoms and are found by accident. When symptoms do appear, they fall into two groups: those from pressure (the tumour pushing on nearby structures) and those from hormone changes.

Pressure (mass effect) symptoms, more common with larger tumours:

• Headaches.
• Vision problems — classically a loss of the outer edges of vision, because the tumour presses on the nerves that carry sight. Cleveland Clinic notes vision is affected in a substantial proportion of people with macroadenomas.
• Tiredness, weakness, or other signs that the normal gland is being squeezed and underproducing hormones (called hypopituitarism).

Hormone-related symptoms depend on the type:

• Prolactin excess: irregular or absent periods, infertility, milk leaking from the breasts when not breastfeeding, reduced sex drive, or erectile difficulties in men.
• Growth hormone excess (acromegaly): the NHS describes gradually enlarging hands and feet, changes in facial features, a deeper voice, increased sweating, joint pain, and tiredness.
• Cortisol excess (Cushing's disease): weight gain around the trunk and face (a rounded "moon" face), easy bruising, muscle weakness, high blood pressure, and mood changes.
• Thyroid hormone excess: weight loss, a fast heartbeat, sweating, and anxiety.

When to see a doctor: arrange a non-urgent appointment if you notice unexplained changes in vision, persistent headaches, ongoing tiredness, or the hormone-related changes above. Seek emergency care for a sudden, severe "thunderclap" headache with sudden vision loss, which can signal a rare complication called pituitary apoplexy (bleeding into the tumour).

There is no routine screening test for pituitary tumours in the general population, and major health bodies do not recommend one. Because most growths are harmless and never cause problems, scanning everyone would do more harm than good.

In practice, pituitary tumours are found in three ways. Some are discovered when symptoms prompt a doctor to investigate. Some are picked up by chance on a brain scan ordered for an unrelated reason — these are called incidentalomas. And some are looked for deliberately in people known to have an inherited condition such as MEN1, where regular hormone tests and scans may be advised by a specialist.

The most useful thing you can do is to take new, persistent symptoms seriously and see your doctor. Because the changes can be gradual — slowly enlarging hands in acromegaly, or a slowly narrowing field of vision — they are easy to dismiss. Mentioning them early gives the best chance of a straightforward path to diagnosis.

If a pituitary tumour is suspected, the assessment usually combines hormone tests, imaging, and a vision check. None of these is painful, and they build a clear picture together.

• Blood tests. These measure pituitary and related hormones — prolactin, growth hormone and a marker called IGF-1, cortisol and ACTH, thyroid hormones, and sex hormones — to see whether any are too high or too low. MedlinePlus lists these as the standard hormone investigations.
• Urine or saliva tests. For suspected Cushing's disease, cortisol may be measured in a 24-hour urine collection or a late-night saliva sample, as the NHS describes.
• MRI scan. Magnetic resonance imaging is the main way to see the gland and any tumour, showing its size and whether it is pressing on nearby structures. A CT scan is sometimes used instead.
• Vision (visual field) test. If the tumour is near the sight nerves, an eye specialist maps your field of vision to check for any loss at the edges.

Pituitary adenomas are not given the numbered "stages" used for many cancers, because they rarely spread. Instead, doctors describe them by size (micro- or macroadenoma), by which hormone (if any) they overproduce, and by how far they extend into surrounding tissue. After surgery, a sample is examined under a microscope to confirm the type and check that it is benign.

Treatment is tailored to the type, size, and effects of the tumour, and it is guided by a multidisciplinary team — typically a neurosurgeon, an endocrinologist (hormone specialist), an ear-nose-throat surgeon, an eye specialist, a radiation specialist, and specialist nurses. Not every tumour needs active treatment. There are three main approaches, often combined.

Watchful waiting. Cancer Research UK notes that a small tumour found by chance, causing no symptoms, may simply be monitored with periodic MRI scans rather than treated straight away.

Medication. For a prolactinoma, medicines called dopamine agonists (such as cabergoline or bromocriptine) are usually the first treatment and can shrink the tumour and lower prolactin in most people — Cleveland Clinic reports good results in around 80% of cases — often avoiding surgery altogether. Other medicines can help control hormone levels in acromegaly or Cushing's disease.

Surgery. For most other tumours, surgery is the main treatment. The usual operation is endoscopic transsphenoidal surgery — the surgeon reaches the gland through the nose and the sphenoid sinus, so there is no visible scar on the face or head. Cleveland Clinic notes this approach is used for the large majority of pituitary tumours. The goal is to remove the tumour while preserving as much healthy gland as possible. A craniotomy (through an opening in the skull) is reserved for unusual cases.

Radiotherapy. Carefully targeted radiation, including stereotactic radiosurgery, may be used when surgery cannot remove all of the tumour, when it returns, or when medication and surgery have not fully controlled it.

Supportive (hormone replacement) care. If the tumour or its treatment leaves the gland underactive, missing hormones — such as thyroid, cortisol, or sex hormones — are replaced with medication. This is a normal, manageable part of care and is overseen by the endocrinologist.

For most people, the outlook after treatment of a benign pituitary tumour is good, and many return to a full and normal life. Because these tumours are almost always non-cancerous, the conversation is usually about controlling symptoms and hormone levels rather than survival. The exact picture depends on the type and size of the tumour and how it responds to treatment, so the most reliable guide to your own situation is your specialist team.

A few realistic points worth knowing. Some tumours can come back over time, which is why long-term follow-up matters; Cleveland Clinic reports that a minority of non-functioning adenomas and prolactinomas eventually need further treatment. Surgery or the tumour itself can leave parts of the gland underactive, and Cleveland Clinic notes that a notable share of people need ongoing hormone replacement — this is well-managed with tablets or injections. Vision problems caused by pressure often improve after the tumour is removed, especially when treated promptly.

These are population-level patterns drawn from medical organisations, not a prediction for any one person. Your age, general health, the tumour's behaviour, and how early it was treated all shape your individual path, which your own doctors are best placed to discuss with you.

Living with, or after, a pituitary tumour usually means a settled routine of monitoring rather than constant treatment. Cancer Research UK and the NHS describe follow-up that typically includes:

• Regular check-ups to review symptoms and how you are feeling.
• Periodic MRI scans to watch the gland and check the tumour has not regrown.
• Hormone blood tests to fine-tune any replacement medication and confirm levels stay in the right range.
• Vision checks if the tumour was near the sight nerves.

If you take hormone replacement, it is important to take it as prescribed and not to stop suddenly. People who replace cortisol are usually given a "sick-day rules" plan — extra doses during illness, injury, or surgery — and may carry a medical alert card or bracelet; your endocrinologist will explain this. Many people also find that tiredness, mood changes, and adjusting to a long-term condition take time. It is completely reasonable to ask your team about support, and to lean on family, friends, or patient organisations. Keeping a simple record of your symptoms, medications, and scan dates makes appointments easier and helps everyone involved in your care.

If you are considering treatment in another country, it helps to understand what shapes the overall cost and how to prepare so that any estimate you receive is accurate. We do not list prices here, because every case is different and only a personalised quote based on your records is meaningful. Arranging a free consultation is the best way to get a realistic figure for your situation.

Factors that affect cost typically include:

• The type of treatment — medication alone, transsphenoidal surgery, radiotherapy, or a combination.
• The tumour's size and complexity, and whether it has grown into nearby structures.
• The tests needed, such as MRI, hormone blood panels, and vision assessment.
• Hospital stay and the level of care required after surgery.
• Follow-up — scans, hormone tests, and any ongoing replacement medication.
• Practical extras such as travel, accommodation, interpreting, and aftercare coordination.

To prepare your records, gather your most recent MRI or CT scans (ideally the image files, not just the report), all hormone blood-test results, a list of your current medications and doses, a summary of your symptoms and how they have changed, and any previous specialist letters. Having these ready lets a team review your case properly and give you a clear, individual plan and estimate.

Turkiye has become a well-established destination for international patients seeking neurosurgery and endocrine care, with hospitals that treat patients from many countries and offer English-speaking coordination, modern imaging, and the full multidisciplinary teams that pituitary care requires. The aim of choosing carefully is not to find the "best" clinic — no honest provider can claim that — but to find a safe, experienced centre that is right for you.

Things worth checking before you commit:

• Accreditation. Look for hospitals with recognised international quality accreditation (for example, Joint Commission International, JCI) alongside local licensing.
• A genuine multidisciplinary team. Pituitary surgery works best where a neurosurgeon experienced in transsphenoidal operations works closely with an endocrinologist, an ENT surgeon, an eye specialist, and a dedicated radiology service.
• Experience with pituitary cases specifically, not just general neurosurgery.
• Clear information on what is and is not included, the planned follow-up, and how complications would be handled.
• Communication in a language you understand, and a written treatment plan you can share with your doctor at home.

It is always reasonable — and wise — to seek a second opinion and to have your home doctor review any plan. A trustworthy centre will welcome this.

There is no proven way to prevent a pituitary tumour, because most arise from random cell changes. But there is a great deal you can do to look after yourself and get the best from your care.

• Take symptoms seriously. Mention vision changes, persistent headaches, unexplained tiredness, or hormone-related changes to your doctor rather than waiting.
• Keep your follow-up appointments and scans. Monitoring is how problems are caught early and managed gently.
• Manage your general health. Some pituitary conditions raise the risk of high blood pressure, diabetes, or thinning bones; staying active, eating well, not smoking, and attending recommended health checks all help, as the NHS advises for acromegaly and Cushing's.
• Ask for a second opinion. For something as important as pituitary surgery, it is completely normal to want another specialist's view before deciding. Good doctors expect and support this.
• Ask about clinical trials. For rarer or harder-to-treat tumours, your team may mention research studies testing new treatments. Cancer Research UK notes you can ask whether any are suitable for you.

Above all, remember that a pituitary tumour is, for most people, a treatable and manageable condition. With the right team, careful monitoring, and clear information, the vast majority of people do well.